España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cis bio international - talio 201 cloruro - soluciÓn inyectable - 37 mbq/ml - talio 201 cloruro 37 mbq - talio (201tl), cloruro de

Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ferring s.a. - triptorelina acetato - polvo y disolvente para suspensiÓn inyectable - 3,75 mg - triptorelina acetato 3.75 mg - triptorelina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ferring s.a. - triptorelina acetato - soluciÓn inyectable - 0,1 mg - triptorelina acetato 0.1 mg - triptorelina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cis bio international - galio 67ga citrato - soluciÓn inyectable - 74 mbq/ml - galio 67ga citrato 74 mbq - galio (67ga), citrato de

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

cis bio international - ytrio y-90 citrato - suspensiÓn inyectable - 37 - 370 mbq/ml inyectable 15 ml - ytrio y-90 citrato 37-370 mbq - itrio (90y) citrato coloidal

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ipsen pharma s.a. - triptorelina - polvo y disolvente para suspensiÓn inyectable - 11,25 mg - triptorelina 11.25 mg - triptorelina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ipsen pharma s.a. - triptorelina acetato - polvo y disolvente para soluciÓn inyectable - 0,1 mg - triptorelina acetato 0.1 mg - triptorelina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ipsen pharma s.a. - triptorelina - polvo y disolvente para suspensiÓn inyectable - 3,75 mg - triptorelina 3.75 mg - triptorelina